UK MPs reject proposed ban on hybrid embryo research Mike Rosen-Molina at 5:24 PM ET
[JURIST] UK legislators Monday voted 336-176 against a proposed ban [Human Fertilisation and Embryology Bill materials] on the use of human-animal hybrid embryo stem cells [JURIST news archive] in scientific and medical research. The decision was highly controversial, with many ban proponents arguing that it was necessary to prevent potential attempts at human genetic engineering. In a Sunday editorial [text] in the Observer, UK Prime Minister Gordon Brown advocated against the ban, saying that hybrid embryos may help stem cell research find cures for degenerative diseases:
It was in 1998 that James Thomson, a scientist at the University of Wisconsin, successfully removed stem cells from spare embryos at fertility clinics.
His discovery established the world's first human embryonic stem cell line and launched stem cell research into the scientific mainstream.
A decade on from that moment of discovery, Parliament will make decisions this week that will affect not only the pace of scientific advance, but also the rights of different individuals to benefit from scientific advances already made in the complex field of embryology.
Should scientists be given the legal framework they say they need to pursue new cures and treatments through stem cell research or will we turn our back on these potential advances?
Should children who face death or critical illness find new hope in scientific advances that would allow their new brother or sister to be not just a blessing to their family, but also a saviour sibling to them? And should people be able to approach IVF clinics without fear of discrimination on the grounds of their sexual orientation?
My answer to all those questions is an unequivocal yes.
Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible, ad-free format.